Groupe la Francaise
NVAX icon

Groupe la Francaise’s Novavax NVAX Stock Holding History

Groupe la Francaise’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-500
Closed -$3.65K – 670
2025
Q3 		$3.65K Buy
+500
New +$3.89K ﹤0.01% 668

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Shah Capital Management Raleigh, North Carolina $605M AUM 43.69% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Groupe la Francaise's NVAX Position: Q4 2025 in Review

Groupe la Francaise sold out of Novavax (NVAX) in Q4 2025, closing a stake of 500 shares — an estimated $3.65K sold.

Groupe la Francaise first reported a position in NVAX in Q3 2025 and held it in 1 quarter. The position peaked at $3.65K in Q3 2025. 235 funds tracked by Wall St. Rank hold NVAX as of Q4 2025.

  • Groupe la Francaise reported no remaining Novavax position as of Q4 2025 after selling out during the quarter.
  • Groupe la Francaise sold 500 Novavax shares in Q4 2025, an estimated $3.65K.
  • Groupe la Francaise first reported a position in Novavax in Q3 2025 and held it in 1 quarter.
  • Groupe la Francaise's Novavax position peaked at $3.65K in Q3 2025.
  • 235 funds tracked by Wall St. Rank held Novavax as of Q4 2025.

Based on Groupe la Francaise's 13F filing for Q4 2025, filed 12 Feb 2026.